RecruitingNCT04359836
A Study to Explore the Role of Gut Flora in COVID-19 Infection
A Non-Interventional Pilot Study to Explore the Role of Gut Flora in COVID-19 Infection
Sponsor
ProgenaBiome
Enrollment
250 participants
Start Date
Apr 16, 2020
Study Type
OBSERVATIONAL
Conditions
Summary
This study seeks to determine whether the virus which causes COVID-19, SARS-CoV-2, is shed in the stools of patients who are infected.
Eligibility
Min Age: 18 Years
Plain Language Summary
Simplified for easier understanding
This study examines the relationship between the gut microbiome — the community of bacteria living in your intestines — and COVID-19 infection. Emerging evidence suggested that COVID-19 severity might be influenced by gut flora composition, and this study aims to document how infection changes the microbiome and whether those changes correlate with disease outcomes.
Participants provide stool samples for microbiome analysis at multiple time points around the time of their COVID-19 infection. This is an observational study — no treatments are given — but findings could inform future treatments targeting the gut.
You may be eligible if:
- You are 18 or older
- You have a confirmed COVID-19 diagnosis by RT-PCR within the past week
You may NOT be eligible if:
- You have had bariatric surgery, total colectomy, or removal of the rectum
- You have a postoperative stoma, ostomy, or ileoanal pouch
- You are on total parenteral nutrition (TPN)
Talk to your doctor to see if this trial is right for you.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
OTHERThere is no intervention in this study
There is no intervention in this study
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04359836
Related Trials
A Study Evaluating MDX2301 in Healthy Adults and Adults at Higher Risk for Severe COVID-19.
NCT074459712 locations
Analysis of Suicidal Behavior Among Children and Adolescents in the Auvergne-Rhone-Alpes Region During the Covid 19 Pandemic Period
NCT073022954 locations
Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study
NCT0380892267 locations
A Study to Evaluate the Immunogenicity and Safety of mRNA-1283 COVID-19 Variant-containing Formulations
NCT070897065 locations
A Safety and Immunogenicity Trial of Boost-2867 Vaccine, Via Intranasal and Intramuscular Routes
NCT072211628 locations